Nipocalimab pivotal Phase 3 trial demonstrates longest sustained[...]
Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at[...]
Tel Instrument Electronics Corporation
Annual Report for Fiscal Year Ending March 31, 2024 (Form 10-K)
05/10/2024 | Press release | Distributed by Public on 05/09/2024 23:36
Please select the service you want to use:
Smartlinks | UnipolSai Assicurazioni S.p.A. | Unipol Gruppo Finanziario S.p.A. | Company News | Securities Issuers | Multiline Insurance and Brokers | Borsa Italiana | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Vienna Stock Exchange (ATX) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | OTC Markets | BX Swiss | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Aquis Exchange | SIGMA X MTF | Equiduct | Euronext Block MTF | Turquoise
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact